丹参酮对女性乳腺癌与妇科癌症的抗癌作用
本文综述丹参脂溶性成分丹参酮II、丹参酮I、隐丹参酮和二氢丹参酮I在乳腺癌及妇科癌症中的抗肿瘤作用与分子机制。体内外研究显示这些化合物通过不同分子机制发挥抗肿瘤活性,为后续研究与临床应用提供参考。
要点
- 丹参酮类成分在体内外对乳腺癌和妇科癌症显示抗肿瘤活性。
- 丹参酮II、丹参酮I、隐丹参酮和二氢丹参酮I通过不同分子机制发挥作用。
- 丹参因活血化瘀、增加氧化应激等作用已用于肝病和心血管疾病。
核心结论
- 丹参酮类化合物在乳腺癌和妇科癌症中具有抗肿瘤活性,相关机制研究为临床应用提供参考。
研究设计与样本
- 本文为综述,汇总丹参酮类成分在乳腺癌和妇科癌症中抗肿瘤作用及机制的最新研究进展。
主要发现
- 丹参酮II、丹参酮I、隐丹参酮和二氢丹参酮I在体内外对妇科癌症显示良好抗肿瘤活性。
- 上述化合物通过不同分子机制发挥抗肿瘤作用。
临床怎么用
- 丹参酮类成分可能作为乳腺癌和妇科癌症研究的候选化合物,但临床应用于肿瘤治疗仍需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Female breast cancer, ovarian cancer, cervical cancer, and endometrial cancer are the most common tumors and the most common causes of cancer-related mortality worldwide in women. Drugs derived from natural plants play important roles in malignant tumor therapy. Salvia miltiorrhiza is a commonly used Chinese herb which has been used in the treatment of liver diseases and cardiovascular diseases because of its positive effect of promoting blood circulation, increasing oxidative stress, and removing blood stasis. Recently, studies have found that fat-soluble components of Salvia miltiorrhiza such as tanshinone II, tanshinone I, cryptotanshinone, and dihydrotanshinone I displayed good antitumor activity in vivo and in vitro for gynecological cancer by different molecular mechanisms. In this study, the latest research progress on the antitumor effect and mechanism of tanshinone compounds in breast cancer and gynecological cancer was reviewed to provide references for the research and clinical application of these compounds (tanshinone II, tanshinone I, cryptotanshinone, and dihydrotanshinone I).
引用
- Jin Z, Chenghao Y, Cheng P, et al. Anticancer Effect of Tanshinones on Female Breast Cancer and Gynecological Cancer. Front Pharmacol. 2022. PMID: 35145409. doi:10.3389/fphar.2021.824531
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。